Business Wire

UPF

14.9.2021 19:12:12 CEST | Business Wire | Press release

Share
UNIVERSAL PEACE FEDERATION: World Leaders Renew Call for Peace on the Korean Peninsula During Rally of Hope Showcase of Think Tank 2022

World leaders and experts renewed their calls for peaceful reconciliation on the Korean Peninsula during the virtual Rally of Hope September 12 (KST). The event, broadcasted live from South Korea and attended by millions of online participants from around the world, featured the Universal Peace Federation’s (UPF) new initiative, Think Tank 2022 , which seeks to build a global strategy for a major breakthrough for peace by the end of 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914005985/en/

“I truly believe that an extraordinary future awaits the people of North Korea — and I have faith that if they pursue the path of denuclearization, they will make that future a magnificent reality,” former U.S. President Donald Trump said in remarks prepared for the event. “Until that blessed day comes, the indispensable force for peace on the Korean Peninsula remains a strong America. As we have seen recently in other parts of the world, weakness only invites more violence and chaos.”

The rally, the seventh such event since August 2020, is among the growing efforts of UPF Co-Founder Dr. Hak Ja Han Moon to address worldwide challenges, including poverty, equality, and environmental degradation, as well as the peaceful reunification of the Korean Peninsula. “Now the time has come for Korea to fulfill its responsibility,” Dr. Moon said at the event. “[T]he prospects for peace on the Korean Peninsula are excellent. This will happen.”

Dr. Moon and her late husband, the Rev. Dr. Sun Myung Moon, are both natives of what is now North Korea and dedicated their lives toward reunifying their homeland and building a more peaceful world. The online rally, which was live-streamed in the U.S. on September 11, included a solemn prayer engaging the global audience in honor of the thousands of lives lost in the 2001 terror attacks.

Other rally speakers included Samdech Hun Sen , prime minister of Cambodia; José Manuel Barroso , former president of the European Commission; Gloria Macapagal Arroyo , former president of The Philippines; H.D. Deve Gowda , former Indian prime minister; Anthony Thomas Aquinas Carmona , former president of Trinidad and Tobago; and Nataša Mićić , former Serbian president.

“As a country placing priceless value upon peace, Cambodia highly appreciates the organization of this rally to strengthen the culture of peace and mutual trust under the framework of international cooperation in the Asia-Pacific area,” said Prime Minister Sen , whose Asian Vision Institute will serve as the Asia-Pacific Secretariat of Think Tank 2022 . He recalled when Phnom Penh was captured by the Khmer Rouge in 1975 during the Cambodian Civil War, saying, “We remember the tragedy and are determined to prevent such a similar event from happening again... We vividly understand that peace and nation-building can only be achieved by the local stakeholders in the conflicting country.”

Four governors of South Korean provinces, as well as newly elected Seoul Mayor Oh See-hoon , Gwangju Mayor Lee Yong-sup , and Busan Mayor ​​Park Heong-joon , congratulated Dr. Moon and UPF for the work to advance reconciliation and cooperation on the peninsula. Mr. Barroso , speaking from his longtime experience leading the European Commission, said he strongly supports Korean reunification. “What the global community can do, and I believe it should do even more, is to show strong support to facilitate [and] create the best external conditions for the Koreans themselves to find a way for true reconciliation and peace,” he said.

In her remarks, Mrs. Arroyo said, “With leaders Kim Jong-un and Moon Jae-in exchanging letters since April and announcing the restoration of several communication channels in July — including a military link demolished by the North last year — let Korea’s example teach the world that peace can thrive if humanity can dream together.”

Mr. Carmona said, “Collaborative goodwill is the engine of any successful peace process. Reunification and reconciliation require genuine maturity rather than filibustering, a meeting of the minds and hearts, celebrating the common good — not revisiting the painful past, but rather connecting to the intergenerational and intragenerational hope, ambition, and vision of a united Korean people.”

Think Tank 2022 , which is developing Expert Working Groups (EWGs) linked to UPF’s seven international associations, will spearhead peacebuilding projects such as a UN Peace Park on the DMZ, building a Korea-Japan undersea tunnel, boosting Geumgang Mountain tourism development, helping separated Korean families find their relatives, and a call for the UN to establish an office in Korea. Think Tank 2022 has already hosted numerous webinars and will also carry out fact-finding consultations, international leadership conferences, and a major World Summit in South Korea implementing a “One Million People's Relief Association.”

The work of UPF globally aims at promoting constructive dialogue among leaders from all sectors and with diversity of political, philosophical and ideological points of view. In a world characterized too often by polarization and an unwillingness to respectfully engage with those who represent “the other side,” UPF seeks to foster a wider dialogue — a political ecumenism that breaks down barriers and charts a path to mutual respect and understanding. Nowhere is such an approach more desperately needed than that of the Korean Peninsula. For this reason, UPF is engaging with leaders of nations and political parties that are allied with both North and South Korea and are guided by principles of respect, civility, and a commitment to reconciliation.

For additional information about Think Tank 2022 , please click Here

Link:

ClickThru

Social Media:

https://www.facebook.com/upf.europe/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye